Skip to search formSkip to main contentSkip to account menu

MK-0826

National Institutes of Health

Related topics

Related topics

1 relation
L 749345

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Isolates pneumoniae and Escherichia coli Clinical -Lactamase-Producing Klebsiella β -Lactamase-and Extended-Spectrum β (L-749,345) against Broad-Spectrum Broad-Spectrum Carbapenem MK-0826 In Vitro…
2003
2003
[Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
The in vitro activity of ertapenem (MK-0826), a new carbapenem, was studied against 389 aerobic microorganisms (187… 
2003
2003
[New Beta-lactam agent in the treatment of intra-abdominal sepsis: double blind and randomized stage III study of ertapenem versus piperacillin/tazobactam].
The clinical and safety efficacy of a new wide spectrum beta-lactam agent for most pathogen intra-abdominal infection germs is… 
2002
2002
Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes.
Review
2002
Review
2002
Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects.
Ertapenem sodium (trade name Invanz, also designated as MK-0826, MK-826 and L-749345), manufactured by Merck & Co., Inc. is a… 
2002
2002
Efficient one-pot synthesis of the 2-aminocarbonylpyrrolidin-4-ylthio-containing side chain of the new broad-spectrum carbapenem antibiotic ertapenem.
An efficient synthesis of the 2-aminocarbonylpyrrolidin-4-ylthio containing side chain of ertapenem (MK-0826) is described… 
2002
2002
In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials.
Highly Cited
2001
Highly Cited
2001
In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia
ABSTRACT Ertapenem (MK-0826, L-749,345) is a 1-β-methyl carbapenem with a long serum half-life. Its in vitro activity was… 
Highly Cited
2001
Highly Cited
2001
In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers
ABSTRACT This study compared the in vitro activities of the new long-half-life carbapenem ertapenem (also known as MK-0826 and L… 
2001
2001
In Vitro Evaluation of Ertapenem (MK-0826), a Long-Acting Carbapenem, Tested Against Selected Resistant Strains
Abstract Ertapenem (MK-0826) is a novel, long-acting parenteral carbapenem. The purpose of this In Vitro study was to test… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)